文献速递甲状腺与颈部外科

机器人甲状腺切除术适应证扩展的回顾性研究

Expanding indications of robotic thyroidectomy.
PubMed 文献 · Surg Endosc · 2018-01-16

本研究回顾性分析80例接受机器人全甲状腺切除术的甲状腺癌患者,其中40例归为更晚期组(肿瘤大于2 cm或可疑包膜侵犯或中央淋巴结转移)。结果显示两组手术安全性和完整性参数无显著差异,提示机器人甲状腺切除术用于更晚期甲状腺癌的结果与早期癌相当,但需多中心研究证实。

要点

  • 机器人甲状腺切除术在更晚期甲状腺癌中安全性与早期癌相当
  • 两组 Retrieved LN 数、刺激后甲状腺球蛋白水平无显著差异
  • 结论需多中心设计良好的研究进一步验证

核心结论

  • 更晚期甲状腺癌患者接受机器人甲状腺切除术的结果与早期癌组相当。

研究设计与样本

  • 40例术前病理或影像提示肿瘤大于2 cm或可疑包膜侵犯或中央淋巴结转移者归为更晚期组,其余为早期组。

主要发现

  • 更晚期组肿瘤更大、甲状腺外侵犯更多、T分期更高。
  • 低钙血症、声带麻痹及其他并发症等安全性参数两组无显著差异。
  • 检索淋巴结平均数、刺激后甲状腺球蛋白中位值及刺激后甲状腺球蛋白小于1 ng/mL的患者比例两组无显著差异。

临床怎么用

  • 在严格选择的更晚期甲状腺癌患者中,机器人甲状腺切除术可作为安全可行的术式选择。
  • 需结合术前评估肿瘤大小、包膜侵犯及中央淋巴结转移情况个体化决策。

局限性

  • 单中心、单术者、小样本回顾性研究,证据等级有限。
  • 需多中心设计良好的研究证实适应证扩展的有效性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Robotic thyroidectomy has many advantages with comparable oncologic safety over conventional open surgery in low-risk differentiated thyroid cancer cases. However, there have been few reports on the outcomes of patients who have been treated with robotic thyroidectomy for more advanced thyroid cancer. The aim of this study was to investigate the validity of expanding indications of robotic thyroidectomy for more advanced thyroid cancer. METHODS: The data of 80 patients with thyroid cancer who underwent robotic total thyroidectomy between January 2013 and December 2014 performed by a single surgeon at Chung-Ang University Hospital were retrospectively reviewed. Among them, 40 patients who had cancer larger than 2 cm or suspicious capsular invasion, or central lymph node (LN) metastasis in preoperative pathologic and radiologic examinations were categorized into the more advanced thyroid cancer group and the remaining patients into the early thyroid cancer group. We compared surgical safety and surgical completeness parameters between the two groups. RESULTS: The patients in more advanced thyroid cancer group had larger tumors, more extrathyroidal extension, and higher T stages. Surgical safety parameters, such as hypoparathyroidism, vocal cord palsy, and other complications did not differ significantly between the two groups. Surgical completeness parameters, such as the mean number of retrieved LNs, median values of the stimulated thyroglobulin levels, and the proportion of patients with stimulated thyroglobulin levels less than 1 ng/mL, also did not differ significantly. CONCLUSIONS: The outcomes of the patients with more advanced thyroid cancer who were treated with robotic thyroidectomy were comparable to those of the early cancer group patients. Well-designed investigations that are conducted at multiple centers are needed to affirm the validity of expanding indications of robotic thyroidectomy.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Paek SH, Kang KH, Park SJ, et al. Expanding indications of robotic thyroidectomy. Surg Endosc. 2018. PMID: 29340816. doi:10.1007/s00464-018-6067-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。